We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. Classification of anticancer drugs: an update with FDA- and EMA-approved drugs

    Anticancer systemic therapy comprises a complex and growing group of drugs. Some of the new agents with novel mechanisms of action that have appeared...

    Lorena Ostios-Garcia, Daniel Martínez Pérez, ... Enrique Espinosa in Cancer and Metastasis Reviews
    Article Open access 05 July 2024
  2. Metabolic adaptations in prostate cancer

    Prostate cancer is one of the most commonly diagnosed cancers in men and is a major cause of cancer-related deaths worldwide. Among the molecular...

    Mikel Pujana-Vaquerizo, Laura Bozal-Basterra, Arkaitz Carracedo in British Journal of Cancer
    Article Open access 05 July 2024
  3. The effect of erythropoiesis‑stimulating agents on lung cancer patients: a meta‑analysis

    Previous studies have demonstrated that erythropoiesis-stimulating agents (ESAs) can reduce anemia and improve quality of life in cancer patients,...

    Zhenhua Tong, Zhumeng Xu, ... Bin Qi in Clinical and Experimental Medicine
    Article Open access 05 July 2024
  4. NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer

    Background

    Radioresistance is the leading cause of death in advanced cervical cancer (CC). Dysregulation of RNA modification has recently emerged as a...

    Min Yu, Mengdong Ni, ... Guihao Ke in Molecular Cancer
    Article Open access 05 July 2024
  5. A new framework for the diagnosis, staging and management of obesity in adults

    Luca Busetto, Dror Dicker, ... Gijs H. Goossens in Nature Medicine
    Article 05 July 2024
  6. lncRNA FLJ20021 regulates CDK1-mediated PANoptosis in a ZBP1-dependent manner to increase the sensitivity of laryngeal cancer-resistant cells to cisplatin

    In this study, we investigated the role of the newly discovered lncRNA FLJ20021 in laryngeal cancer (LC) and its resistance to cisplatin treatment....

    **aoyan Yin, Haizhong Zhang, ... Chunguang Shan in Discover Oncology
    Article Open access 05 July 2024
  7. Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial

    It remains unclear whether metronomic chemotherapy is superior to conventional chemotherapy when combined with immune checkpoint blockade. Here we...

    Hongnan Mo, Yongpei Yu, ... Fei Ma in Nature Medicine
    Article 05 July 2024
  8. Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition

    Arteriovenous malformations (AVM) are benign vascular anomalies prone to pain, bleeding, and progressive growth. AVM are mainly caused by mosaic...

    Friedrich G. Kapp, Farhad Bazgir, ... Jochen Rössler in Angiogenesis
    Article Open access 05 July 2024
  9. Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ≥ 75 years: results of a real-world cohort including 456 patients

    Background

    Immune checkpoint inhibitors (ICI) applied in patients with melanoma in an adjuvant setting have proven safety and efficacy in several...

    A. Gawaz, I. Wolff, ... A. Forschner in Cancer Immunology, Immunotherapy
    Article Open access 05 July 2024
  10. Characteristics of adult retroperitoneal lymphangioma: a single center Chinese cohort study of 15 cases

    Background

    Lymphangioma is a rare cystic tumor that occurs across different locations. Retroperitoneal lymphangioma accounts for about 1% of all...

    Jie Liu, Zhi-Han Zhong, Shu-Sen Zheng in Discover Oncology
    Article Open access 04 July 2024
  11. Comprehensive multiomics analysis of the signatures of gastric mucosal bacteria and plasma metabolites across different stomach microhabitats in the development of gastric cancer

    Purpose

    As an important component of the microenvironment, the gastric microbiota and its metabolites are associated with tumour occurrence,...

    Bingsen Wang, Jiahui Luan, ... Mei Shi in Cellular Oncology
    Article Open access 04 July 2024
  12. Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma

    Background

    BRAF inhibitors are widely employed in the treatment of melanoma with the BRAF V600E mutation. However, the development of resistance...

    Byung-Sun Park, Heeju Jeon, ... Tackhoon Kim in Molecular Cancer
    Article Open access 04 July 2024
  13. Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021

    Advances in treatment have improved the survival of multiple myeloma (MM) patients, but the disease remains incurable. Here, in this nationwide...

    Kai Kysenius, Anna Anttalainen, ... Mervi Putkonen in Annals of Hematology
    Article 04 July 2024
  14. 3D airway geometry analysis of factors in airway navigation failure for lung nodules

    Background

    This study aimed to quantitatively reveal contributing factors to airway navigation failure during radial probe endobronchial ultrasound...

    Hwan-ho Cho, Junsu Choe, ... Ho Yun Lee in Cancer Imaging
    Article Open access 04 July 2024
  15. Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapy

    Background

    Endocrine therapy is the most important treatment modality of breast cancer patients whose tumors express the estrogen receptor α (ERα)....

    Huanyao Gao, Lixuan Wei, ... Liewei Wang in Breast Cancer Research
    Article Open access 04 July 2024
  16. Advancements in the understanding and management of histiocytic neoplasms

    Histiocytic neoplasms are rare diseases involving macrophages, dendritic cells, and monocytes. They include Langerhans cell histiocytosis (LCH),...

    Kyung-Nam Koh, Su Hyun Yoon, ... Ho Joon Im in Blood Research
    Article Open access 04 July 2024
  17. Promoter profiles in plasma CfDNA exhibits a potential utility of predicting the efficacy of neoadjuvant chemotherapy in breast cancer patients

    Background

    Gene expression profiles in breast tissue biopsies contain information related to chemotherapy efficacy. The promoter profiles in cell-free...

    Xu Yang, Qing Liu, ... Yingsong Wu in Breast Cancer Research
    Article Open access 04 July 2024
  18. Extension of efficacy range for targeted malaria-elimination interventions due to spillover effects

    Malaria-elimination interventions aim to extinguish hotspots and prevent transmission to nearby areas. Here, we re-analyzed a cluster-randomized...

    Jade Benjamin-Chung, Haodong Li, ... Michelle S. Hsiang in Nature Medicine
    Article Open access 04 July 2024
Did you find what you were looking for? Share feedback.